Featured Articles

Kendle Appoints Patricia Williams Vice President, Commercial Operations

Kendle Appoints Patricia Williams Vice President, Commercial Operations

May 06 2008 | comment(s)

CINCINNATI, May 6 /PRNewswire/ --

- Industry Veteran to Lead Global Contract Execution and Negotiation Efforts

Kendle (Nasdaq: KNDL), a leading, global full-service clinical research organization (CRO), today announced the appointment of Patricia Williams to the position of Vice President, Commercial Operations. In this newly created position, Williams will provide leadership for global contract execution and negotiation with the company's biopharmaceutical customers, including master service agreements and changes in scope. Williams will be based in Kendle's European headquarters in Crowthorne, England and will report directly to Chris Bergen, Chief Operating Officer.

(Logo: http://www.newscom.com/cgi-bin/prnh/20030429/KNDLLOGO )

Genetic Variation In Mitochondria Linked To Macular Degeneration

Genetic Variation In Mitochondria Linked To Macular Degeneration

May 06 2008 | comment(s)

Genetic variation in the DNA of mitochondria – the 'power plants' of cells – contributes to a person’s risk of developing age-related macular degeneration (AMD), say investigators in the first study to examine the mitochondrial genome for changes associated with AMD, the leading cause of blindness in Caucasians over age 50.

“Most people don’t realize that we have two genomes,” said lead author Jeff Canter, M.D., M.P.H., an investigator in the Center for Human Genetics Research. “We have the nuclear genome – the “human genome” – that makes the cover of all the magazines, and then we also have this tiny genome in mitochondria in every cell.”

Canter teamed with Jonathan Haines, Ph.D., and Paul Sternberg, M.D., experts in AMD genetics and treatment, to examine whether a particular variation in the mitochondrial genome is associated with the disease. The genetic change occurs in about 10 percent of Caucasians, referred to as mitochondrial haplogroup T.

16 Telecommunications Companies Sign Agreement To Build High-Bandwidth Undersea Cable System From UK To India

16 Telecommunications Companies Sign Agreement To Build High-Bandwidth Undersea Cable System From UK To India

May 06 2008 | comment(s)

LONDON, May 6 /PRNewswire/ --

Major leaders of the global telecommunications industry Tuesday (May 6) signed a construction and maintenance agreement (C&MA) to build the first direct, high-bandwidth optical-fiber submarine cable system from the United Kingdom to India. The Europe India Gateway (EIG) cable system, which will cost more than US$700 million, will significantly enhance capacity and diversity between the countries of these regions.

Sixteen telecommunications companies are investing in the project: AT&T; Bharti Airtel; BT; Cable &Wireless; Djibouti Telecom; Du; Gibtelecom; IAM; Libyan Post, Telecom and Information Technology Company; MTN Group Ltd; Omantel; PT Comunicacoes, S.A.; Saudi Telecom Company; Telecom Egypt; Telkom SA Ltd; and Verizon Business.

Verizon Business Joins Consortium To Build Undersea Cable System Between Europe And India

Verizon Business Joins Consortium To Build Undersea Cable System Between Europe And India

May 06 2008 | comment(s)

LONDON, May 6 /PRNewswire/ --

- Company's Participation in EIG Enhances Leading Global Network Capabilities

Verizon Business Tuesday (May 6) joined a consortium of 16 companies building a next-generation undersea optical cable system connecting Europe, the Middle East and India.

The new system, named the Europe India Gateway (EIG), is the third major submarine cable project Verizon Business has helped launch in the last four years and continues the company's global network leadership in delivering more capacity, reliability and speed for the data, video and voice services of its multinational customers.

Distinguished Emissions Trading Experts To Lead Workshops At The 2nd Carbon Trading Conference In New York

Distinguished Emissions Trading Experts To Lead Workshops At The 2nd Carbon Trading Conference In New York

May 06 2008 | comment(s)

NEW YORK, May 6 /PRNewswire/ --

Imtiaz Ahmad, Executive Director of Morgan Stanley's Carbon Trading group will present on the infrastructure of carbon trading in an interactive workshop setting outlining the mechanisms currently set in place and compare the pros and cons of alternative trading strategies and products. Other workshop leaders include Shawn Burns, CEO of Carbon Credit Corp, Milo Sjardin, Head of North America at New Carbon Finance, Tina Reine, Vice President, Carbon Markets at JP Morgan Chase, and Jeffrey Fort, Partner at Sonnenschein Nath & Rosenthal LLP.

What can happen when geneticists play God:

What can happen when geneticists play God:

May 06 2008 | comment(s)

Nerdy comics don't get any funnier than xkcd:
Petrobras To Participate In Global Event On Sustainability And Transparency

Petrobras To Participate In Global Event On Sustainability And Transparency

May 06 2008 | comment(s)

RIO DE JANEIRO, Brazil, May 6 /PRNewswire/ --

From May 7 to 9, Petrobras will advance discussions on issues such as sustainable development and biofuels during the Amsterdam Conference on Sustainability and Transparency. The event, held by the Global Reporting Initiative (GRI), the world's biggest reference in sustainability report preparation, will bring more than a thousand participants together in Amsterdam, The Netherlands.

Alcatel-Lucent To Hold Media And Analyst Tutorial Webcast On Industry & Public Sector (IPS) Activities On May 20, 2008

Alcatel-Lucent To Hold Media And Analyst Tutorial Webcast On Industry & Public Sector (IPS) Activities On May 20, 2008

May 06 2008 | comment(s)

PARIS, May 6 /PRNewswire/ -- Alcatel-Lucent (Euronext Paris and NYSE: ALU) today announced that Michael Fabian, President of Industry and Public Sector for Alcatel-Lucent's services activities will deliver a media tutorial on the IPS market on May 20, 2008 at 3.00 PM Paris time (9 AM New York time). Michael Fabian will explain the communications needs of this sector and how Alcatel-Lucent is uniquely positioned to deliver solutions to solve its communications challenges.

Northrop Grumman Park Air Systems Appoints Eldar Hauge Managing Director Of Park Air Systems Norway Operations

Northrop Grumman Park Air Systems Appoints Eldar Hauge Managing Director Of Park Air Systems Norway Operations

May 06 2008 | comment(s)

LONDON, May 6 /PRNewswire/ --

Northrop Grumman Corporation (NYSE: NOC) has announced the appointment of Eldar Hauge as managing director of its Northrop Grumman Park Air Systems operations in Norway. Northrop Grumman Park Air Systems is a leading provider of communication, navigation and surveillance systems for air-space operations worldwide.

A photo accompanying this release is available at: http://media.primezone.com/noc/

In this role, Hauge will be responsible for establishing and maintaining Northrop Grumman's relationships with existing and potential customers in Norway and for strengthening the company's ability to pursue new business opportunities in the international air traffic management market.

Gene Therapy Safety Examined Using Adult Stem Cells

Gene Therapy Safety Examined Using Adult Stem Cells

May 06 2008 | comment(s)

A new study by UC Davis researchers provides evidence that methods using human bone marrow-derived stem cells to deliver gene therapy to cure diseases of the blood, bone marrow and certain types of cancer do not cause the development of tumors or leukemia. The study was published online in the May 6, 2008 issue of Molecular Therapy.

"The results of our decade-long study of adult human stem cell transplantation shows that there is little risk of adverse events caused by gene transfer, and that adult human stem cells do not pose a cancer risk when implanted into different organs," said Jan Nolta, senior author of the study and director of the UC Davis Stem Cell Program.

Nolta and her colleagues tested the safety of gene transfer into bone marrow stem cells from human donors in more than 600 mice. None of the transplanted mice developed leukemia or solid tumors caused by the gene therapy treatment, during the evaluation period of up to 18 months.

Dilon Technologies Receives CE Mark For Medical Imaging System

Dilon Technologies Receives CE Mark For Medical Imaging System

May 06 2008 | comment(s)

NEWPORT NEWS, Virginia, May 6 /PRNewswire/ --

- Gamma Camera sales to be launched in Europe

Dilon Technologies announced today that it has received CE Mark (Conformite Europeenne) approval for the commercial sale of the Dilon 6800 Gamma Camera in European Union member countries. The Dilon system is a high-resolution gamma camera that enables molecular imaging of the breast and other small organs for early cancer detection.

Dalton Pharma Services Licenses Thermo Fisher Scientific Technology To Produce Polynucleotides For Drug Development

Dalton Pharma Services Licenses Thermo Fisher Scientific Technology To Produce Polynucleotides For Drug Development

May 06 2008 | comment(s)

TORONTO, May 6 /PRNewswire/ -- Dalton Pharma Services, a privately owned Canadian pharmaceutical services provider, and Thermo Fisher Scientific have entered into an agreement under which Dalton will use a proprietary Thermo Fisher manufacturing process to produce nucleic-acid biopolymers for pharmaceutical use.

Stiefel Laboratories, Inc. Acquires ABR Invent And ABR Development

Stiefel Laboratories, Inc. Acquires ABR Invent And ABR Development

May 06 2008 | comment(s)

CORAL GABLES, Florida, May 6 /PRNewswire/ --

- Acquisition of dermal filler product enhances company's aesthetic portfolio

Stiefel Laboratories, Inc., the world's largest independent pharmaceutical company specializing in dermatology, announced today that it has acquired ABR Invent and ABR Development, developers of the dermal filler Atlean(R).

Stiefel will acquire all shares of ABR Invent and ABR Development through a definitive stock purchase agreement. Both ABR Invent and ABR Development are legal entities based in France.

SAND Welcomes Tom O'Donnell To Board Of Directors

SAND Welcomes Tom O'Donnell To Board Of Directors

May 06 2008 | comment(s)

MONTREAL, May 6 /PRNewswire/ --

Synopsys Invests In Prover Technology

Synopsys Invests In Prover Technology

May 06 2008 | comment(s)

MOUNTAIN VIEW, California and STOCKHOLM, Sweden, May 6 /PRNewswire/ --

- Investment highlights growth in worldwide railway control, command and signaling technology

Synopsys, Inc. (Nasdaq: SNPS), a world leader in software and IP for semiconductor design and manufacturing, and Prover Technology AB today announced that Synopsys has invested in Prover, which supplies signaling design automation solutions for engineering the safety critical systems that control trains, switches and signals. The funds will enable Prover to accelerate its research and development efforts and expand its operations in Europe, North America and Asia.

Oil Refineries Gives Notice Of Extraordinary General Meeting On June 10, 2008

Oil Refineries Gives Notice Of Extraordinary General Meeting On June 10, 2008

May 06 2008 | comment(s)

HAIFA, Israel, May 6 /PRNewswire/ -- Oil Refineries Ltd. (TASE: ORL.TA) (the "Company"), Israel's largest oil refiner, announced today the convening of an Extraordinary General Meeting. See below announcement translated from Hebrew.

Notice is hereby given that, on June 10, 2008, at 10:00 a.m., an Extraordinary General Meeting of the Company's Shareholders shall convene, at the Company's offices, located on the 26th floor of the Azrieli Centre, Square Building, 132 Menachem Begin Street, Tel Aviv, Israel, for the purpose of approving the following resolutions:

On the agenda:

Purchasing a Directors' and Position Holders Liability Insurance

GoldenSource Reports Strong Q1 EDM Sales, Announces New Strategic Hires And Moves Into New London Facility

GoldenSource Reports Strong Q1 EDM Sales, Announces New Strategic Hires And Moves Into New London Facility

May 06 2008 | comment(s)

MedImmune Fortifies Strategic Scientific Portfolio Management And International Leadership With New Executive Appointments

MedImmune Fortifies Strategic Scientific Portfolio Management And International Leadership With New Executive Appointments

May 06 2008 | comment(s)

GAITHERSBURG, Maryland, May 6 /PRNewswire/ --

The American Psychiatric Association's Awards For Young Scientists Encourage Research Expertise In China

The American Psychiatric Association's Awards For Young Scientists Encourage Research Expertise In China

May 06 2008 | comment(s)

WASHINGTON, DC, May 6 /PRNewswire/ --

- International Reach of 'Young Minds in Psychiatry' Awards is Boosted With AstraZeneca Support

Addax Petroleum Announces Record First Quarter 2008 Results

Addax Petroleum Announces Record First Quarter 2008 Results

May 06 2008 | comment(s)

CALGARY, Canada, May 6 /PRNewswire/ --

- 78 per cent Increase in Funds Flow From Operations to US$469 Million

- 204 per cent Increase in Net Income to US$240 Million

- 20 per cent Increase in Production to 139.1 Mbbl/d

Addax Petroleum Corporation ("Addax Petroleum" or the "Corporation") (TSX:AXC and LSE:AXC), today announced its results for the quarter ended March 31, 2008. The financial results are prepared in accordance with Canadian GAAP and the reporting currency is US dollars.